A Study on the Efficacy of Atezolizumab Combined with Chemotherapy

A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

NCT04063163 ·Status: COMPLETED ·Phase: PHASE3

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

NCT05224141 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy

NCT02813785 ·Status: COMPLETED ·Phase: PHASE3

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

NCT03811002 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

NCT02409342 ·Status: COMPLETED ·Phase: PHASE3

Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04005716 ·Status: COMPLETED ·Phase: PHASE3

PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC

NCT06375109 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]

NCT02367794 ·Status: COMPLETED ·Phase: PHASE3

A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT02366143 ·Status: COMPLETED ·Phase: PHASE3

A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

NCT04256421 ·Status: COMPLETED ·Phase: PHASE3

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

NCT04691063 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

NCT06712355 ·Status: RECRUITING ·Phase: PHASE3

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

NCT04379635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

NCT07322341 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

NCT03191786 ·Status: COMPLETED ·Phase: PHASE3

Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC).

NCT06663098 ·Status: RECRUITING ·Phase: PHASE2

A Study of Atezolizumab With or Without Tiragolumab Consolidation in Limited Stage Small Cell Lung Cancer

NCT04308785 ·Status: TERMINATED ·Phase: PHASE2

Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC)

NCT02179528 ·Status: UNKNOWN ·Phase: PHASE2

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

NCT04920981 ·Status: COMPLETED

Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

NCT04214262 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer

NCT04542369 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer

NCT04728724 ·Status: RECRUITING ·Phase: PHASE2

Liver Directed RT + Chemo-immunotherapy for ES-SCLC

NCT04923776 ·Status: TERMINATED ·Phase: PHASE2

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

NCT02927301 ·Status: COMPLETED ·Phase: PHASE2

A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)

NCT02657434 ·Status: COMPLETED ·Phase: PHASE3